Serum Levels and Clinical Effect of Flucloxacillin in Patients with Staphylococcal Infections
- 1 September 1974
- journal article
- clinical trial
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 6 (3) , 273-278
- https://doi.org/10.3109/inf.1974.6.issue-3.11
Abstract
25 patients with infections with penicillinase-producing methicillin-sensitive Staphylococcus aureus strains were treated by oral administration of flucloxacillin. In 12 of the patients the serum concentration was measured after administration of 0.5 or 1.0 g 3 times a day. After the smaller dose the average serum level was 24 μg/ml in fasting patients and 17 μg/ml in those who had taken the drug in association with a meal. The corresponding values after administration of 1.0 g were 35 and 26 μg/ml, respectively. In both groups the peak serum level occurred, on the average, one hour after intake of the antibiotic. In 14 of 16 patients with deep infections the effect of treatment was regarded as good. In 9 patients with skin infections the effect was initially good. Three of the patients complained of malaise, but the symptom could not be ascribed to the antibiotic.Keywords
This publication has 7 references indexed in Scilit:
- Flucloxacillin: A new semisynthetic isoxazolyl penicillinClinical Pharmacology & Therapeutics, 1972
- Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and DicloxacillinBMJ, 1970
- The Concentration of Penicillin V in Serum and Middle Ear Exudate in Acute Otitis Media in ChildrenScandinavian Journal of Infectious Diseases, 1969
- Mechanisms Responsible for the Blood Level Differences of Isoxazolyl PenicillinsArchives of internal medicine (1960), 1968
- Clinical pharmacology of the new penicillins: I. The importance of serum protein binding in determining antimicrobial activity and concentration in serumClinical Pharmacology & Therapeutics, 1966
- DicloxacillinArchives of internal medicine (1960), 1965
- A NEW ORALLY EFFECTIVE PENICILLINASE-STABLE PENICILLIN— BRL. 1621The Lancet, 1962